What happens to the bone structure after normocalcemic primary hyperparathyroidism surgery?

被引:8
|
作者
Osorio-Silla, Irene [1 ]
Gomez-Ramirez, Joaquin [2 ]
Valdazo-Gomez, Adela [3 ]
Salido Fernandez, Sergio [1 ]
Sanchez Garcia, Carmen [1 ]
Pardo Garcia, Ricardo [1 ]
机构
[1] Univ Hosp Fdn Jimenez Diaz, Dept Surg, Madrid, Spain
[2] Univ Hosp Ramon Y Cajal, Dept Surg, Madrid, Spain
[3] Univ Hosp Infanta Leonor, Dept Surg, Madrid, Spain
关键词
MINERAL DENSITY; TURNOVER MARKERS; PARATHYROIDECTOMY; OUTCOMES;
D O I
10.1016/j.surg.2021.08.047
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Bone disease in primary hyperparathyroidism is a clear indication for surgical treatment. However, it is not known whether surgery benefits hypercalcemic primary hyperparathyroidism and normocalcemic primary hyperparathyroidism equally. The aim of our study was to evaluate the bone changes in patients undergoing parathyroidectomy based on the biochemical profile 1 and 2 years after surgery. Methods: This prospective study included 87 consecutive patients diagnosed with primary hyperparathyroidism who underwent surgery between 2016 and 2018. Bone densitometry (1/3 distal radius, lumbar, and femur) and bone remodeling markers (osteocalcin, type 1 procollagen [P1NP], beta-cross-linked telopeptide of type I collagen [BCTX]) were performed preoperatively and postoperatively. Postoperative changes in bone mineral density and bone markers were compared and evaluated according to the clinical characteristics and the individual biochemical profile. Results: One year after surgery, all patients showed an increase in bone mineral density at the lumbar site (mean, 0.029 g/cm(2); range, 0.017-0.04; P < .001) and femur neck (mean, 0.025 g/cm(2); range, 0.002-0.05; P < .001); however, there were no changes in the distal third of the radius (mean, -0.003 g/cm(2); range, -0.008 to 0.002; P = NS). There were no significant differences when comparing normocalcemic primary hyperparathyroidism and hypercalcemic primary hyperparathyroidism. Serum osteocalcin (37 +/- 17.41), P1NP (67.53 +/- 31.81) and BCTX (0.64 +/- 0.37) levels were elevated before surgery. One year after the surgery, we observed a significant decrease in P1NP (33.05 +/- 13.16, P = .001), osteocalcin (15.80 +/- 6.19, P = .001), and BCTX (0.26 +/- 0.32, P < .001) levels. . Conclusion: Our findings indicate that parathyroidectomy has similar benefits for normocalcemic primary hyperparathyroidism and hypercalcemic primary hyperparathyroidism in terms of bone improvement. Although the most substantial improvement occurred during the first postoperative year in both groups, we consider that studies with longer follow-up are warranted. (C) 2021 Elsevier Inc. All rights reserved.
引用
收藏
页码:932 / 939
页数:8
相关论文
共 50 条
  • [21] DXA-based bone strain index in normocalcemic primary hyperparathyroidism
    Tabacco, Gaia
    Naciu, Anda Mihaela
    Messina, Carmelo
    Sanson, Gianfranco
    Rinaudo, Luca
    Cesareo, Roberto
    Falcone, Stefania
    Napoli, Nicola
    Ulivieri, Fabio Massimo
    Palermo, Andrea
    OSTEOPOROSIS INTERNATIONAL, 2023, 34 (05) : 999 - 1003
  • [22] Comparisons Between Normocalcemic Primary Hyperparathyroidism and Typical Primary Hyperparathyroidism
    Choi, Hye Ryeon
    Choi, Sun Hyung
    Hong, Namki
    Rhee, Yumie
    Kim, Jin Kyong
    Lee, Cho Rok
    Kang, Sang-Wook
    Lee, Jandee
    Jeong, Jong Ju
    Nam, Kee-Hyun
    Chung, Woong Youn
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2022, 37 (13)
  • [23] Paget Disease of Bone and Normocalcemic Primary Hyperparathyroidism: an uncommon association.
    Tara, Vasireddy Nayana
    Mori, Krishna S.
    Balachandran, Karthik
    Asirvatham, Adlyne Reena
    Mahadevan, Shriraam
    JOURNAL OF BONE AND MINERAL RESEARCH, 2022, 37 : 77 - 78
  • [24] DXA-based bone strain index in normocalcemic primary hyperparathyroidism
    Gaia Tabacco
    Anda Mihaela Naciu
    Carmelo Messina
    Gianfranco Sanson
    Luca Rinaudo
    Roberto Cesareo
    Stefania Falcone
    Nicola Napoli
    Fabio Massimo Ulivieri
    Andrea Palermo
    Osteoporosis International, 2023, 34 : 999 - 1003
  • [25] DXA-BASED BONE STRAIN INDEX IN NORMOCALCEMIC PRIMARY HYPERPARATHYROIDISM
    Tabacco, G.
    Messina, C.
    Rinaudo, L.
    Falcone, S.
    Cesareo, R.
    Manfrini, S.
    Napoli, N.
    Ulivieri, F. M.
    Palermo, A.
    Naciu, A.
    OSTEOPOROSIS INTERNATIONAL, 2021, 32 (SUPPL 1) : S336 - S336
  • [26] Normocalcemic versus Hypercalcemic Primary Hyperparathyroidism: More Stone than Bone?
    Amaral, L. M.
    Queiroz, D. C.
    Marques, T. F.
    Mendes, M.
    Bandeira, F.
    JOURNAL OF OSTEOPOROSIS, 2012, 2012
  • [27] A practical approach to normocalcemic primary hyperparathyroidism
    José Luis Muñoz de Nova
    Miguel Sampedro-Nuñez
    Isabel Huguet-Moreno
    Mónica Marazuela Azpiroz
    Endocrine, 2021, 74 : 235 - 244
  • [28] Parathyroidectomy outcomes in normocalcemic primary hyperparathyroidism
    Alvarez-Allende, Carlos R.
    Pascual Marrero, Annette M.
    Castillo, Cesar A.
    Mendez-Latalladi, William
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2014, 219 (04) : E12 - E12
  • [29] A CASE OF NORMOCALCEMIC PRIMARY HYPERPARATHYROIDISM WITH OSTEOMALACIA
    SHIMADA, I
    INABA, M
    NAKANO, H
    MIKI, T
    NISHIZAWA, Y
    MORII, H
    ENDOCRINOLOGIA JAPONICA, 1986, 33 (05): : 575 - 582
  • [30] Is Normocalcemic Primary Hyperparathyroidism Harmful or Harmless?
    Chen, Gang
    Xue, Ying
    Zhang, Qiongyao
    Xue, Ting
    Yao, Jin
    Huang, Huibin
    Liang, Jixing
    Li, Liantao
    Lin, Wei
    Lin, Lixiang
    Shi, Lidan
    Cai, Liangchun
    Wen, Junping
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2015, 100 (06): : 2420 - 2424